Surgical Science Sweden AB (publ) (SUSRF)
OTCMKTS · Delayed Price · Currency is USD
3.410
-0.220 (-6.06%)
At close: Dec 29, 2025
SUSRF Market Cap
SUSRF has a market cap or net worth of $137.21 million as of February 12, 2026. Its market cap has decreased by -83.12% in one year.
Market Cap
137.21M
Enterprise Value
70.24M
Revenue
103.48M
Ranking
n/a
PE Ratio
18.52
Stock Price
$3.41
Market Cap Chart
Since June 19, 2017, SUSRF's market cap has increased from 32.05M to 137.21M, an increase of 328.17%. That is a compound annual growth rate of 18.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 137.21M | -23.95% |
| Dec 30, 2025 | 180.43M | -74.95% |
| Dec 30, 2024 | 720.24M | -22.00% |
| Dec 29, 2023 | 923.33M | 15.03% |
| Dec 30, 2022 | 802.66M | -49.23% |
| Dec 30, 2021 | 1.58B | 301.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 766.76M |
| Revium Rx. | 91.09M |
| Vaso Corporation | 31.06M |
| Veri Medtech Holdings | 20.00M |
| Pharma-Bio Serv | 13.59M |
| CareView Communications | 13.51M |
| Welsis | 12.66M |
| BioRegenx | 12.50M |